{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:04:19Z","timestamp":1784642659953,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["U105963071"],"award-info":[{"award-number":["U105963071"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS050509-01A1"],"award-info":[{"award-number":["NS050509-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bone.2021.116183","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T10:47:49Z","timestamp":1632912469000},"page":"116183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development of tibia &amp; fibula bone deficits in children with neurofibromatosis type I \u2013 A longitudinal case-control comparison"],"prefix":"10.1016","volume":"154","author":[{"given":"Alex","family":"Ireland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Eelloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Zulf","family":"Mughal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate A.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bone.2021.116183_bb0005","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/ajmg.a.33045","article-title":"Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options","volume":"149A","author":"Elefteriou","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"issue":"11","key":"10.1016\/j.bone.2021.116183_bb0010","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/jbmr.1685","article-title":"A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age","volume":"27","author":"Heerv\u00e4","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116183_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpeds.2006.10.048","article-title":"Bone mineral density in children and adolescents with neurofibromatosis type 1","volume":"150","author":"Stevenson","year":"2007","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.bone.2021.116183_bb0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bone.2008.12.002","article-title":"Tibial geometry in individuals with neurofibromatosis type 1 without anterolateral bowing of the lower leg using peripheral quantitative computed tomography","volume":"44","author":"Stevenson","year":"2009","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2021.116183_bb0025","first-page":"145","article-title":"Case-control study of the muscular compartments and osseous strength in neurofibromatosis type 1 using peripheral quantitative computed tomography","volume":"5","author":"Stevenson","year":"2005","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"4","key":"10.1016\/j.bone.2021.116183_bb0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/(SICI)1096-8628(19991203)87:4<317::AID-AJMG7>3.0.CO;2-X","article-title":"Neurofibromatosis type 1 growth charts","volume":"87","author":"Clementi","year":"1999","journal-title":"Am. J. Med. Genet."},{"issue":"401","key":"10.1016\/j.bone.2021.116183_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00003086-200208000-00013","article-title":"Orthopaedic manifestations of neurofibromatosis in children: an update","author":"Vitale","year":"2002","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"2","key":"10.1016\/j.bone.2021.116183_bb0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01202412-200004000-00001","article-title":"The fibula in congenital pseudoarthrosis of the tibia: the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS)","volume":"9","author":"Keret","year":"2000","journal-title":"J. Pediatr. Orthop. B"},{"issue":"5","key":"10.1016\/j.bone.2021.116183_bb0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/(SICI)1096-8628(19990611)84:5<413::AID-AJMG5>3.0.CO;2-1","article-title":"Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1","volume":"84","author":"Stevenson","year":"1999","journal-title":"Am. J. Med. Genet."},{"issue":"5","key":"10.1016\/j.bone.2021.116183_bb0050","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ajmg.a.35541","article-title":"Fractures in children with neurofibromatosis type 1 from two NF clinics","volume":"161A","author":"George-Abraham","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"issue":"1","key":"10.1016\/j.bone.2021.116183_bb0055","first-page":"27","article-title":"Characterisation of peripheral bone mineral density in youth at risk of secondary osteoporosis - a preliminary insight","volume":"20","author":"Jenkins","year":"2020","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"2","key":"10.1016\/j.bone.2021.116183_bb0060","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00198-016-3779-0","article-title":"Meagre effects of disuse on the human fibula are not explained by bone size or geometry","volume":"28","author":"Ireland","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.116183_bb0065","series-title":"WHO Child Growth Standards: Length\/Height for Age, Weight-for-Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age, Methods and Development","author":"World Health Organisation","year":"2006"},{"issue":"6","key":"10.1016\/j.bone.2021.116183_bb0070","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1542\/peds.66.6.918","article-title":"Adolescents\u2019 self-assessment of sexual maturation","volume":"66","author":"Duke","year":"1980","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.bone.2021.116183_bb0075","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/ajmg.a.36001","article-title":"The generalized bone phenotype in children with neurofibromatosis 1: a sibling matched case-control study","volume":"161A","author":"Armstrong","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bone.2021.116183_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12018-013-9151-4","article-title":"The influence of muscular action on bone strength via exercise","volume":"12","author":"Ireland","year":"2013","journal-title":"Clin. Rev. Bone Min. Metab."},{"issue":"4","key":"10.1016\/j.bone.2021.116183_bb0085","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jpeds.2010.10.001","article-title":"Mental, motor, and language development of toddlers with neurofibromatosis type 1","volume":"158","author":"Lorenzo","year":"2011","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.bone.2021.116183_bb0090","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/jbmr.2775","article-title":"Motor competence in early childhood is positively associated with bone strength in late adolescence","volume":"31","author":"Ireland","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116183_bb0095","first-page":"111","article-title":"Vitamin D status and muscle function in children with neurofibromatosis type 1 (NF1)","volume":"13","author":"Hockett","year":"2013","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"8","key":"10.1016\/j.bone.2021.116183_bb0100","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/dmcn.12777","article-title":"Muscle weakness in children with neurofibromatosis type 1","volume":"57","author":"Cornett","year":"2015","journal-title":"Dev. Med. Child Neurol."},{"issue":"6","key":"10.1016\/j.bone.2021.116183_bb0105","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/jpc.14764","article-title":"Perceived fatigue in children and young adults with neurofibromatosis type 1","volume":"56","author":"Vassallo","year":"2020","journal-title":"J. Paediatr. Child Health"},{"issue":"3","key":"10.1016\/j.bone.2021.116183_bb0110","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1359\/jbmr.071103","article-title":"Longitudinal changes in BMD and bone geometry in a population-based study","volume":"23","author":"Lauretani","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.bone.2021.116183_bb0115","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s001980070020","article-title":"Peak bone mass","volume":"11","author":"Heaney","year":"2000","journal-title":"Osteoporos. Int."},{"issue":"9","key":"10.1016\/j.bone.2021.116183_bb0120","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/jbmr.1631","article-title":"Habitual levels of high, but not moderate or low, impact activity are positively related to hip BMD and geometry: results from a population-based study of adolescents","volume":"27","author":"Deere","year":"2012","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221003495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:44:17Z","timestamp":1762659857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221003495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":24,"alternative-id":["S8756328221003495"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116183","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of tibia & fibula bone deficits in children with neurofibromatosis type I \u2013 A longitudinal case-control comparison","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116183"}}